PROGRAM

  • Wednesday, September 23
  • Thursday, September 24
  • Friday, September 25

Wednesday, September 23

[SY1B]
Hospital transfusion management

Safe and appropriate use of blood products is very important in a blood transfusion. According to the addition of the paragraph regarding the establishment and operation of the Hospital Transfusion Committee and the Blood Transfusion Management Office in hospitals to the Korean Blood Management Act, these mandatories will be implemented from December 2020, and hospitals that perform blood transfusions need to be prepared. The goal of the session is to help hospitals to prepare countermeasures.

Date & Time Sept. 23 (Wed), 10:30-12:00 Venue Room B Language Kor (Simultaneous interpreting)
Speaker(s)
  1. TBD
    Sinyoung Kim, Yonsei University College of Medicine, Korea
  2. TBD
    Tae Hyun Um, Inje University College of Medicine, Korea
  3. TBD
    Hyung Hoi Kim, Pusan National University School of Medicine, Korea
  4. TBD
    Seon Joo Kang, Davos Hospital, Korea

[SY1C]
Policy Trends in Laboratory Medicine

In this session, current policy issues related to laboratory medicines, will be introduced and discussed. Those issues are approval of national reference laboratory for infectious diseases, the third revision of relative value score, and exemption of informed consent in collecting residual samples for research.

Date & Time Sept. 23 (Wed), 10:30-12:00 Venue Room C Language Kor
Speaker(s)
  1. TBD
    Jae-Sun Park, Korea Centers for Disease Control and Prevention, Korea
  2. TBD
    Woochang Lee, University of Ulsan College of Medicine, Korea
  3. TBD
    Sang Hoon Song, Seoul National University College of Medicine, Korea

[SY2A]
Improving laboratory productivity through IT system

Clinical laboratory continues to improve in productivity with the development of technology. One of the most important factor in laboratory productivity is IT system. Laboratory can handle large amounts of data and information quickly and easily with advanced it system. We're not IT professionals, so the IT still sounds like a distant talk, and it feels like a difficult area to accomplish. With this session, we would like to share experiences and explore the new technology.

Date & Time Sept. 23 (Wed), 13:00-14:30 Venue Room A Language Eng
Speaker(s)
  1. TBD
    Jaehoon Choi, EONE Laboratories, Korea
  2. TBD
    Soo Hyun Kim, Seegene Medical Foundation, Korea
  3. TBD
    HackJin Lee, DoAI Inc., Korea
  4. TBD
    Eun-Hae Cho, Green Cross Genome, Korea

[SY2B]
Education workshop for residents and new specialists in laboratory medicine

Overview: This session is intended for residents in training, new starters, or laboratory medicine specialists with interests of basic knowledge. We will be covering the very basics and practical aspects of laboratory medicine in the fields of laboratory management, clinical chemistry, diagnostic hematology, and clinical microbiology.

Date & Time Sept. 23 (Wed), 13:00-14:30 Venue Room B Language Kor (Simultaneous interpreting)
Speaker(s)
  1. Laboratory management & continuous quality improvement
    Woo In Lee, Kyung Hee University School of Medicine, Korea
  2. Therapeutic drug monitoring
    Soo-Youn Lee, Sungkyunkwan University School of Medicine, Korea
  3. Laboratory investigations for bleeding disorders
    Sung Ran Cho, Ajou University School of Medicine, Korea
  4. Rapid diagnostic tests in clinical microbiology laboratory
    Yu Kyung Kim, Kyungpook National University School of Medicine, Korea

[SY2C]
Education course for laboratory medicine specialist

Overview: This session is an essential education program to qualify as a laboratory medicine specialist. And the program covers the whole of the laboratory management, evaluation of resident training and laboratory information necessary for instruction of residents.

Date & Time Sept. 23 (Wed), 13:00-17:00 Venue Room C Language Kor
Speaker(s)
  1. Qualification and role of resident training staff
    Yongjung Park, Yonsei University College of Medicine, Korea
  2. TBD
    Saeam Shin, Yonsei University College of Medicine, Korea
  3. The Role of clinical pathologist in the laboratory management
    Sung-Eun Cho, LabGenomics Clinical Laboratories, Korea
  4. Maintenance and function checks for laboratory equipment
    Eun-Jung Cho, Hallym University College of Medicine, Korea
  5. Performance evaluation protocols of laboratory measurement procedures for laboratory medicine specialist
    Tae-Dong Jeong, Ewha Womans University College of Medicine, Korea
  6. Statistical internal quality control
    Sang-Guk Lee, Yonsei University College of Medicine, Korea
  7. TBD
    Yun Ji Hong, Seoul National University College of Medicine, Korea

[SY3B]
Convergent evolution of specialists in the mid-sized hospitals

Overview: This session is designed to provide specialists and residents with a good foundation knowledge in all aspects of specialist's role in the mid-sized hospitals to improve abilities to solve real-world problems.

Date & Time Sept. 23 (Wed), 14:30-15:30 Venue Room B Language Kor (Simultaneous interpreting)
Speaker(s)
  1. Proper antibiotics usage in middle sized hospital
    Youn Jeong Kim, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Korea
  2. Subclinical iron deficiency in non-anemic korean health examinees
    Eun-Hee Nah, Korea Association of Health Promotion, Korea
  3. Chief information officer (CIO) role of laboratory medicine specialist in small and medium-sized hospital
    Yungzoon Jung, Nasaret International Hospital, Korea
  4. TBD
    Hyun-Ki Kim, University of Ulsan College of Medicine, Korea

[SY4A]
Artificial intelligence for medical genetics

The development of artificial intelligence using high performance computing power is expected to be the key to solving the complex problems of medical field, which have been difficult to access. In this session, we will discuss the latest knowledge on how AI is applied and what can be achieved in medical genetics.

Date & Time Sept. 23(Wed), 15:30-17:00 Venue Room A Language Eng
Speaker(s)
  1. DNA knows your height and weight: missing heritability, interaction, and artificial intelligence
    Namshin Kim, Korea Research Institute of Bioscience & Biotechnology, Korea
  2. AI-based genomic diagnostics in cancer immunotherapy
    Jung Kyoon Choi, KAIST, Korea
  3. Genome editing using CRISPR
    Hyongbum Kim, Yonsei University College of Medicine, Korea

[SY4B]
Inspector workshop of Korean laboratory accreditation program

Overview: This workshop deals with the accreditation checklist and intends to improve understanding and practical skills required of an inspection team leader and team members.

Date & Time Sept. 23 (Wed), 15:30-17:00 Venue Room B Language Kor (Simultaneous interpreting)
Speaker(s)
  1. Molecular diagnostic assay validation in genetic disorders
    Woori Jang, Inha University School of Medicine, Korea
  2. Quality control in transfusion medicine
    Hyun-Ji Lee, Pusan National University School of Medicine, Korea
  3. Quality control in diagnostic immunology
    Hyeyoung Lee, Catholic Kwandong University College of Medicine, Korea
  4. Surveyor training program for ISQua accreditation
    Jihyang Lim, College of Medicine, The Catholic University of Korea, Korea

[PL01]

Date & Time Sept. 23 (Wed), 17:30-18:30 Venue Room A Language Eng
Speaker(s)
  1. Fusobacterium nucleatum and colorectal cancer
    Kyungwon Lee, Yonsei University College of Medicine, Korea

Thursday, September 24

[SY5C]
External Quality Assurance System

Overview:

Date & Time Sept. 24 (Thu), 08:00-11:00 Venue Room C Language Eng
Speaker(s)
  1. TBD
    Kyunghoon Lee, Seoul National University College of Medicine, Korea
  2. Result of 12 years implementing EQA for medical laboratories in Vietnam
    Truong Quan Thuy, Center for Standardization and Quality control in Medical Lab of Ho Chi Minh City, Vietnam
  3. External quality assurance system in medical laboratories: Myanmar experience
    Wah Wah Aung, Advanced Molecular Research Centre, Myanmar
  4. External quality assurance system in mongolia
    OYUNDELGER Munkhtuvshin Ertsuud, Mongolian Association of the Laboratory Medicine, Mongolia
  5. Risk assessment for external quality assurance choices in clinical laboratories
    Yi-Ching Lin, College of Medicine, Kaohsiung Medical University, Taiwan
  6. External quality assurance system in clinical chemistry: Present status in India
    Praveen Sharma, Department of Biochemistry, All India Institute of Medical Sciences Jodhpur, India
  7. Current status of external quality assurance system in japan
    Katsuo Kubono, Department of Clinical Engineering and Medical Technology, Niigata University of Health and Welfare, Japan
  8. Implementation of national external quality assurance scheme (EQAS) to achieve harmonization of laboratory result: indonesia’s experience
    Agus Susanto Kosasih, Dharmais Hospital National Cancer Center, Jakarta, Indonesia

[SY6A]
Laboratory investigation of hormone and vitamins

Overview: In this session, we will discuss the clinical application of hormone tests used to diagnose and manage endocrine diseases and the recent update of the test methods. We will also look at diagnostic tests that can be used for differential diagnosis of vitamin B12 and folic acid deficiency.

Date & Time Sept. 24 (Thu), 08:30-10:00 Venue Room A Language Eng
Speaker(s)
  1. Vitamin B12 and folate deficiency and its laboratory investigation; Comparison of Diagnostic Accuracy of Active B12 and Total Vitamin B12.
    Barnali Das, Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute, India
  2. Laboratory assessment in the diagnosis and management of parathyroid disease
    Soo Young Moon, Pusan National University School of Medicine, Korea
  3. Urine free cortisol in the diagnosis of Cushing’s syndrome
    Jooyoung Cho, Yonsei University Wonju College of Medicine, Korea

[SY6B]
PHEIC (Public Health Emergency of International Concern) & EUA (Emergency Use Authorization)

Overview: WHO declared the COVID-19 outbreak to be a Public Health Emergency of International Concern (PHEIC) on January 30, 2020.
PHEIC is a formal declaration by the WHO of "an extraordinary event which is determined to constitute a public health risk to other States through the international spread of disease and to potentially require a coordinated international response".
In this session PHEIC and EUA (Emergency Use Authorization) in response to the Korea’s coronavirus outbreak will be discussed.

Date & Time Sept. 24 (Thu), 08:30-10:00 Venue Room B Language Eng
Speaker(s)
  1. PHEIC (Public Health Emergency of International Concern)
    Jeong Su Park, Seoul National University College of Medicine, Korea
  2. SARS-CoV-2 & COVID-19 in Korea
    Heungsup Sung, University of Ulsan College of Medicine, Korea
  3. EUA (Emergency Use Authorization) in Korea’s Coronavirus outbreak
    Hyukmin Lee, Yonsei University College of Medicine, Korea

[PL02]
AACC-KSLM Select Session

Date & Time Sept. 24 (Thu), 11:00-12:00 Venue Room A Language Eng
Speaker(s)
  1. Clinical Lab 2.0: How the laboratory can support value based care, optimize patient outcomes, and reduce total costs of care
    David G. Grenache, American Association for Clinical Chemistry, USA

[KS01]

Date & Time Sept. 24 (Thu), 13:00-13:40 Venue Room A Language Eng
Speaker(s)
  1. Genomics, metabolomics and the diagnosis of rare diseases
    Ching-Wan Lam, The University of Hong Kong, Hong Kong

[SY7A]
AACC-KSLM Select Session

If at First You Don’t Succeed: An interactive case-based view of emerging molecular technologies.

Overview: DNA-based molecular technologies are becoming synonymous with precision medicine; however, these tests don’t have all the answers. This session will be an interactive, case-based workshop that will describe approaches to molecular test selection when front-line testing is uninformative. We will review the scientific basis and practical considerations of three emerging technologies that are increasingly used in genomic medicine: RNA-based next-generation sequencing (NGS), droplet digital PCR, and cell-free tumor DNA tests.

Date & Time Sept. 24 (Thu), 13:40-15:10 Venue Room A Language Eng
Speaker(s)
  1. What to do when you don’t have tissue: Cell-free tumor DNA
    Christina Lockwood, University of Washington, USA
  2. What to do when DNA fails: RNA-based next-generation sequencing
    Seung-Tae Lee, Yonsei University College of Medicine, Korea
  3. What to do when you don’t have enough: Droplet digital PCR
    Vera Paulson, University of Washington, USA

[SY7B]
Technical innovation and laboratory medicine and infection control

Infection control is multidisciplinary process and it can be deeply influenced by diagnostic stewardship. Recent innovation in laboratory medicine are helping to effectively manage infection control through rapid results reporting. In this session, the novel technique for diagnosing healthcare-associated infection will be reviewed by some experts.

Date & Time Sept. 24 (Thu), 13:40-15:40 Venue Room B Language Kor
Speaker(s)
  1. TBD
    Ki-Ho Hong, Seoul Medical Center, Korea
  2. New diagnostics test for HAI in primary-care hospitals
    Hyukmin Lee, Yonsei University College of Medicine, Korea
  3. TBD
    YoungJin Kim Kyung, Hee University School of Medicine, Korea
  4. The current status of C. difficile infection diagnosis; meaning of laboratory diagnosis
    Bo-Mun Shin Inje University College of Medicine, Korea

[SY7C]
MFDS-KSLM Session

Date & Time Sept. 24 (Thu), 13:40-15:10 Venue Room C Language Kor
Speaker(s) TBD

[SY8A]
Clinically unmet needs in laboratory hematology

Overview: Diagnostics of hematologic malignancies have recently been experiencing extensive modification due to the incorporation of advanced diagnostic tools into existing workflows. In this session, we will define the role of hematopathologists in the new diagnostic era by discussing the emerging diagnostic issues in the field of hematologic malignancies.

Date & Time Sept. 24 (Thu), 16:00-17:30 Venue Room A Language Eng
Speaker(s)
  1. Next-generation sequencing and next-generation flowcytometry in diagnostics of plasma cell disorder: Is it more useful and informative for treatment in real-world clinical settings?
    Hyun-Young Kim, Sungkyunkwan University School of Medicine, Korea
  2. Diagnostics of myelodysplastic syndrome: Can the genetics open the door to perfect diagnosis?
    Young-Uk Cho, University of Ulsan College of Medicine, Korea
  3. Germline variant screening in myeloid neoplasms: Should it be routinely tested in all patients?
    Borahm Kim, Korea University College of Medicine, Korea

[SY8B]
KCDC-KSLM Session

Date & Time Sept. 24 (Thu), 16:00-17:30 Venue Room B Language Kor
Speaker(s) TBD

[SY8C]

Current state and perspectives of Long Read Sequencing (LRS) technologies
Long read sequencing technologies are expected to overcome the limitations of previous NGS technology to effectively analyze the structural characteristics of the genome and solve the ambiguity of the genetic information. In this session, we will discuss the up-to-date knowledge of long-lead sequencing technology and its application.

Date & Time Sept. 24 (Thu), 16:00-17:30 Venue Room C Language Eng
Speaker(s) TBD

[KS02]

Date & Time Sept. 24 (Thu), 17:30-18:10 Venue Room A Language Eng
Speaker(s)
  1. PML-RARA: Lessons from the chimera and the curable leukemia
    Scott C. Kogan, University of California, USA

Friday, September 25

[SY9A]
Viral infection in transplant patients

Overview: This session will discuss about viral infections that commonly occur in transplant patients.

Date & Time Sept. 25 (Fri), 08:30-10:00 Venue Room A Language Eng
Speaker(s)
  1. Monitoring of viral infections in transplant patients
    Sang-Oh Lee, University of Ulsan College of Medicine, Korea
  2. CMV (Cytomegalovirus) and BK virus infection in transplant patients
    Eun-Jee Oh, College of Medicine, The Catholic University of Korea, Korea
  3. Herpes virus infection in transplant patients
    Hyun Soo Kim, Hallym University College of Medicine, Korea
  4. Viral hepatitis in transplant patients
    Younhee Park, Yonsei University College of Medicine, Korea

[SY9C]
Evidence-based laboratory management and Its convergence with CLSI guidelines

Overview: In this session, we will explore the CLSI standards related to the evidence-based laboratory management and discuss how to apply them to actual laboratories.

Date & Time Sept. 25 (Fri), 08:30-10:00 Venue Room C Language Eng
Speaker(s)
  1. Autoverification of medical laboratory results for specific disciplines (AUTO15)
    Bill Marquardt, Vice President of Laboratory Intelligence at McKesson Laboratory Solutions, USA
  2. Measurement procedure comparison and bias estimation using patient samples (EP09)
    Jeffrey R Budd , Beckman Coulter, Inc., USA
  3. Preliminary evaluation of quantitative clinical laboratory measurement procedures (EP10)
    Hyewon Park, Seegene Medical Foundation, Korea

[PL03]

Date & Time Sept. 25 (Fri), 11:00-12:00 Venue Room A Language Eng
Speaker(s)
  1. Measurement traceability for timeless global harmonization of clinical laboratory testing
    Sang-Ryoul Park, Korea Research Institute of Standards and Science, Korea

[KS03]

Date & Time Sept. 25 (Fri), 13:00-13:40 Venue Room A Language Eng
Speaker(s)
  1. New paradigms in the treatment of massive hemorrhage
    Mark Harris Yazer, Department of Pathology, University of Pittsburgh, USA

[SY10A]
Challenges to maintain an adequate blood transfusion

Overview: Due to the decline of the blood donating population and the population aging, we are in a critical situation of blood shortages. In this session, the recent advances in adequate transfusion policy in the patient side will be presented.

Date & Time Sept. 25 (Fri), 14:00-15:30 Venue Room A Language Eng
Speaker(s)
  1. Physiology of anemia and oxygen delivery
    Jun Ho Jang, Division of Hematology Oncology, School of Medicine, Sungkyunkwan University, Korea
  2. Liberal or restrictive transfusion, that is a question
    Leo van de Watering, Center for Clinical Transfusion Research, Sanquin, The Netherlands
  3. Role of a clinical pathologist for blood shortages
    Dong Wook Jekarl, College of Medicine, The Catholic University of Korea, Korea

[SY10B]
Practical Aspects of Laboratory Management (Ⅷ) ; Clinical Laboratory Environment and Safety

Overview: The “Laboratory Management Committee’ will introduce the ‘Clinical Laboratory Environment and Safety’, which are the basic elements for Systematic Laboratory Management.

Date & Time Sept. 25 (Fri), 14:00-15:30 Venue Room B Language Eng
Speaker(s)
  1. Management of reagent water and clinical laboratory waste
    Younhee Park, Yonsei University College of Medicine, Korea
  2. Management of hazardous chemicals
    Kyoung Ho Roh, National Health Insurance Ilsan Hospital, Korea
  3. Clinical laboratory safety
    Yangsoon Lee, Hanyang University College of Medicine, Korea

[SY10C]
CAP

The challenge of laboratory-developed tests: a regulatory and legislative update

Date & Time Sept. 25 (Fri), 14:00-15:30 Venue Room C Language Eng
Speaker(s)